Horizon 2020
BRUNO MOURENZA
Horizon 2020
Punto di Contatto Nazionale
SALUTE
Three Priorities What’s New?
• A single programme
• More innovation –
“from research to retail”
Excellent
science
• Focus on societal
challenges
Industrial
leadership
Societal
challenges
• Simplified and
broader access
2
Struttura del programma
Industrial Technologies
Excellent Science
European Research Council
Frontier research by the best
individual teams
Future and Emerging
Technologies
Collaborative research to open
new fields of innovation
Marie Skłodowska Curie actions
Opportunities for training and
career development
Research infrastructures
(including e-infrastructure)
Ensuring access to world-class
facilities
Societal Challenges
Leadership in enabling and
industrial technologies
ICT, nanotechnologies,
materials, biotechnology,
manufacturing, space
Health, demographic change
and wellbeing
Access to risk finance
Leveraging private finance and
venture capital for research
and innovation
Secure, clean and efficient
energy
Innovation in SMEs
Fostering all forms of
innovation in all types of SMEs
Climate action, resource
efficiency and raw materials
Food security, sustainable
agriculture, marine and
maritime research & the
bioeconomy
Smart, green and integrated
transport
Inclusive, innovative and
reflective societies
Security society
European Institute of Innovation and Technology (EIT)
Spreading Excellence and Widening Participation
Science with and for society
Joint Research Center (JRC)
3
IMPLEMENTAZIONE
Work Programmes H2020
STRATEGIC PROGRAMME: A multi-annual approach (3 years) to help
applicants plan ahead. (note: this could be subject to the vote of
Programme Committee)
WORK PROGRAMMES: 3 Work Programmes (biannual) during the
course of H2020 and 1 final Work Programme for the last year to
bridge to the next programme after 2020
4
H2020 Work Programmes : Multi-annual Programming
2014
2015
2016
2017
2018
Strategic Programme
Strategic Programme
Work Programme 1
Work Programmes mirror
the strategic programme
and are updated over the
same 2-year cycle
2019
2020
Strategic programmes:
short documents
outligning priorities over
3 years, updated every
two years
Work Programme 2
Strategic Programme
Work Programme 3
Work
Programme 4
Smaller and continuous updates to respond to unexpected developments
Calls published
on basis of WP
Ad hoc financing
decision
Calls published
on basis of WP
Ad hoc financing
decision
Calls published
on basis of WP
Ad hoc financing
decision
Calls published
on basis of WP
5
1. HEALTH,
DEMOGRAPHIC
CHANGE
AND
WELLBEING
6
The Horizon 2020 societal challenge of ‘Health, Demographic change and
Wellbeing’ (SC1) for the years 2014 and 2015
Includes 36 topics in the ‘personalising health and care’ focus area call, and 15 topics in the
‘co-ordination activities’ call.
The total budget available is approximately EUR 1.20bn.
Topics in the call are divided into 7 areas.
Societal challenge 1 is also implemented by the Innovative Medicines Initiative (IMI), the
European and Developing Countries Clinical Trials Partnership (EDCTP), the Active and
Assisted Living programme (AAL) and the European Innovation Partnership on Active and
Healthy Ageing (EIP-AHA).
Many topics will be evaluated in two stages. Exceptions to the two stage approach include
a number of ‘close to market’ type topics, including those which make use of the SME
instrument.
The 2014 topics deadlines are as follows:
Two stage calls:
•
Stage 1 – 11 March 2014
•
Stage 2 – 19 August 2014
One stage calls: 15 April 2014
The 2015 topics deadlines are as follows:
Two stage calls:
• Stage 1 – 14 October 2014
• Stage 2 – 24 February 2015
One stage calls: 21 April 2015
7
Understanding the call topics: example
• 'PHC 2 – 2015'
• 'Specific challenge'
• 'Scope'
• 'Expected impact'
• 'Type of action'
8
Where are we now in health?
Call for Personalizing Health and Care 2014-2015
1.1. Understanding health, ageing and disease
1.2. Effective health promotion, disease prevention,
preparedness and screening
1.3. Improving diagnosis
On content?
1.4. Innovative treatments and technologies
1.5. Advancing active and healthy ageing
1.6. Integrated, sustainable, citizen-centred care
1.7. Improving health information, data exploitation
and providing an evidence base for health policies
and regulation
IMI, AAL, EDCTP cutting across
9
Call for Co-ordination activities 2014-2015
1.1. EIP on AHA – European Innovation Partnership on Active and
Healthy Ageing
1.2. JPI – Joint Programming Initiative More Years and Better Lives
1.3. European Reference Networks: Efficient network modelling and
validation
1.4. Global Alliance for Chronic Diseases: prevention and treatment
of type 2 diabetes
1.5. ERA-NETs
- Synergies between JPND (Neurodegenerative Diseases) and H2020
- Cancer Research
- Brain related diseases
- Systems medicine for clinical needs research
- Rare Diseases research implementing IRDiRC objectives
10
Rules of Participation
11
SINGLE SET of RULES
Covering all research and innovation programmes, initiatives and funding bodies
(art. 185 and art. 187 initiatives, EIT,…), but flexible to accommodate specificities where needed
(through delegated acts)
Coherent with the rules contained in the Financial Regulation (FR), but containing
"derogations"
EU FINANCIAL
REGULATION
12
Legal entity participant (art.6)/
Eligibility for funding (art.9)
WHO CAN PARTICIPATE?
WHO CAN BE FUNDED?
Any legal entity established in a MS, associated
country* or third country
Any legal entity established in a MS, associated
country or third country
JRC (Joint Research Centre)
JRC (Joint Research Centre)
International organizations of European
interest
ICPC countries
International organizations and entities
established in third countries fulfilling the
minimum conditions
*Albania, Bosnia-Herzegovina, Croatia, FYR Macedonia, Iceland, Israel,
Liechtenstein, Montenegro, Norway, Serbia, Switzerland, Turkey
International organizations of European
interest
International organizations and entities
established in third countries no ICPC only in case
is required by the WP/ bilateral agreement or if it’s
essential for the action
Possibility of di Joint Call with third countries and international organization
13
ELIGIBILITY for FUNDING
DEFINITIONS
NEW
NO LEGAL PERSONALITY IF
…ANY NATURAL PERSON, OR ANY
LEGAL PERSON CREATED UNDER THE
NATIONAL LAW ,COMMUNITY LAW
OR INTERNATIONAL LAW,
WHICH HAS LEGAL PERSONALITY…
N.A.
‘LEGAL ENTITY’
‘NON-PROFIT
LEGAL ENTITY’
REPRESENTATIVES HAVE THE CAPACITY
TO UNDERTAKE LEGAL OBLIGATIONS
ON BEHALF OF THE ENTITY AND OFFER
GUARANTEES OF PROTECTION OF
UNION’S FINANCIAL INTERESTS
EQUIVALENT TO THOSE OFFERED BY
LEGAL PERSONS
... NON-PROFIT-MAKING LEGAL
FORM OR LEGAL/STATUTORY
OBLIGATION NOT TO DISTRIBUTE
PROFITS TO ITS SHAREHOLDERS OR
INDIVIDUAL MEMBERS
14
CONDITIONS for PARTICIPATION
MINIMUM CONDITIONS
For standard collaborative actions
• At least 3 legal entities, each established in different MS/AC
For SME Instrument, programme co-fund, CSA
• 1 legal entity established in a MS/AC
ADDITIONAL CONDITIONS
To be set out in the Work Programme (i.e. number of participants,
type of participants, etc.)
15
METHOD OF FUNDING (art.5)
Research and Innovation action
Innovation action
NEW
Coordination and Support Actions
Programme Co-funding Actions
Pre-Commercial Procurement (PCP)
Public Procurement of Innovative Solutions (PPI)
PRIZES
NEW
16
TYPES of ACTIONS
INNOVATION ACTION
NEW
DEMONSTRATION ACTIVITY
(REIMBURSED UP TO 50%)
INNOVATION ACTION
ACTIVITIES DIRECTLY AIMING AT
PRODUCING PLANS AND ARRANGEMENTS
OR DESIGNS FOR NEW, ALTERED OR
IMPROVED PRODUCTS, PROCESSES OR
SERVICES. ..MAY INCLUDE PROTOTYPING,
TESTING, DEMONSTRATING, PILOTING,
LARGE-SCALE PRODUCT VALIDATION AND
MARKET REPLICATION
PHC 20 – 2014: Advancing active and healthy ageing with
ICT: ICT solutions for independent living with cognitive
impairment
-Single Stage (15th April 2014)
- Budget: 10 mill EUR
-EU contribution: 2/3 mill EUR (70%)
17
PRIZES
• Recognition prizes (Nobel Prize, DG INFSO's "ICT
Prize", …)= recognition of scientific achievements
already attained
• Inducement Prizes = competition which ‘induce' to
the achievement of a specific goal(Ortieg Prize,
Ansari X-Prize, …).
18
INNOVATION ACTION
SPECIFIC PROCEDURES
B. SME INSTRUMENT
– Implemented just by one Agency (EASME - Executive Agency for
Small and Medium-sized Enterprises).
– Addressed to all kind of innovative SME’s willing to growth,
develop and internationalize. In general, Bottom-Up approach.
– Only SMEs allowed to apply for funding and support (1 SME or
consortium of SMEs)
19
– Oriented to the market: Close-to-Market activity; funded up to 70% or
up to 100% if research activities are predominant.
– “Societal challenges” and “LEIT”
– Continuously open call with several cut-off dates per year: First cut-off
for Phase 1 around June 2014; first cut-off for Phase 2 in autumn
2014.
20
21
SME Definition
Engaged in an economic activity
< 250 employees
Annual turnover ≤ € 50 Millions or annual balance sheet total ≤ € 43 Millions
Autonomous
Definition:
http://ec.europa.eu/enterprise/policies/sme/fa
cts-figures-analysis/sme-definition/index_en.htm
Guide to EU definition of SME:
http://ec.europa.eu/enterprise/enterprise_policy/sme_
definition/sme_user_guide_it.pdf
22
SME INSTRUMENT
Concept & Feasibility
Assessment
Demonstration
Market replication
R&D
Commercialisation
Idea to concept,
risk assessment,
technological & commercial
feasibility
Demonstration, prototyping,
testing , market replication,
scaling up, miniaturisation,
research
Quality label for
successful projects,
access to risk finance,
indirect support
Idea
Pre-Commercial
Procurement
SME window EU
financial facilities
continued support throughout the project
Market
23
SME Instrument in H2020
Industrial Technologies
Excellent Science
European Research Council
Frontier research by the best
individual teams
Future and Emerging
Technologies
Collaborative research to open
new fields of innovation
Marie Skłodowska Curie actions
Opportunities for training and
career development
Research infrastructures
(including e-infrastructure)
Ensuring access to world-class
facilities
Societal Challenges
Leadership in enabling and
industrial technologies
ICT, nanotechnologies,
materials, biotechnology,
manufacturing, space
Health, demographic change
and wellbeing
Access to risk finance
Leveraging private finance and
venture capital for research
and innovation
Secure, clean and efficient
energy
Innovation in SMEs
Fostering all forms of
innovation in all types of SMEs
Food security, sustainable
agriculture, marine and
maritime research & the
bioeconomy
Smart, green and integrated
transport
Climate action, resource
efficiency and raw materials
Inclusive, innovative and
reflective societies
Security society
European Institute of Innovation and Technology (EIT)
Spreading Excellence and Widening Participation
Science with and for society
Joint Research Center (JRC)
24
Phase 3 = 2% budget
SME Instrument
Phase 1: Concept
and feasibility
assessment
Input: Idea/Concept:
"Business Plan 1"
(~ 10 pages)
10% budget
Activities:
Feasibility of concept
Risk assessment
IP regime
Partner search
Design study
Pilot application
etc.
10% success
30-50%
success
Phase 2: R&D,
demonstration, market
replication
Input: "Business plan 2"
plus description of
activities under Phase 2 (~
30 pages)
88% budget
Promote instrument as
quality label for successful
projects
Activities:
Development, prototyping,
testing, piloting,
miniaturisation, scaling-up,
market replication,
research
Support via networking ,
training, information,
addressing i.a. IP
management, knowledge
sharing, dissemination
Output: "investor-ready
Business plan 3"
Output: elaborated
"Business plan 2"
Lump sum: 50.000 €
1-3 (5) M€ EC funding
~ 6 months
~ 12 to 24 months
~2 months evaluation
Phase 3:
Commercialisation
~4 months evaluation
Facilitate access to private
finance
SME window in the EU
financial facilities (debt
facility and equity facility)
Possible connection to PPC
(and PPI?)
No direct funding
25
Criteria (art. 14)
Impact
Criterio 3
Excellence
Criterio 2
Criterio 1
3 CRITERIAS
Quality and
efficiency of
implementation
Possibility of 2-Stages calls
Excellence, unique criteria on ERC actions
High importance of ‘impact’ in the innovation action
26
SIMPLIFIED FUNDING METHOD
REIMBURSEMENT RATES
NEW
• UP TO 100% FOR RESEARCH
AND INNOVATION ACTIONS
• UP TO 70% FOR INNOVATION
(NON-PROFIT ENTITIES UP TO
100%) AND PROGRAMME COFUND ACTIONS
27
SIMPLIFIED FUNDING METHOD
INDIRECT COSTS
STANDARD FLAT RATE (20%)
SPECIAL FLAT RATE (60%)
SIMPLIFIED METHOD or
ACTUAL INDIRECT COSTS
FLAT RATE OF 25% OF TOTAL
DIRECT COSTS, EXCLUDING
SUBCONTRACTING, COSTS OF
THIRD PARTIES AND FINANCIAL
SUPPORT TO THIRD PARTIES
NEW
28
Types of collaborative projects
R&D projects
Close to market
projects
Basic research, applied
research, technology
development and
integration, and testing e
validation on a small scale
prototype in a laboratory
or simulated environment
Prototyping, testing,
demostrating, piloting,
large - scale product
validation and market
replication
29
Types of collaborative projects
30
Funding rates
Cost Category
Direct costs
Funding
Research & Development:
max. 100%
Close-to-market actions:
max. 70%
Exception:
Close-to-market actions for non-profit legal entities:
max.100%
Indirect costs
Flat rate
31 © Fit for Health, 2013
Flat rate:
25% of total direct costs
31
CONTROLS and AUDITS
EX POST AUDIT
NEW
UP TO FIVE YEARS AFTER
THE END OF THE
PROJECT
LIMITED TO TWO YEARS
AFTER THE PAYMENT OF
THE BALANCE
32
OPEN ACCESS
ONLINE ACCESS AT NO CHARGE TO THE USER
• to peer-reviewed scientific publications
• to research data
NEW
SPECIAL CLAUSE 39 (SPECIFIC
FOR FP7 THEMES:
ENVIRONMENT, ENERGY,
HEALTH, ICT, SSH,
INFRASTRUCTURES, SIS)
OBLIGATION TO PROVIDE OA,
EITHER THROUGH THE GREEN
OR GOLD WAY ALLOWED
EMBARGOS: 6/12 MONTHS.
OPEN ACCESS COSTS ELIGIBLE
FOR REIMBURSEMENT
33
Participant Portal and SEP:
general overview of the system.
Starting from the project proposal to
the final report
34
Participant Portal – general information
The Participant Portal is the
single entry point for
electronic administration
of EU-funded research and
innovation projects, and
hosts the services for
managing your proposals
and projects throughout their
lifecycle.
http://ec.europa.eu/research/participants/portal/desktop/en/home.html
35
Participant Portal –main functions
Participant Portal covers:
2014-2020 Horizon 2020 - research and innovation framework programme
2007-2013 7th research framework programme (FP7) and Competitiveness & Innovation
Programme (CIP)
Non-registered users may:
•
search for funding
•
read the funding guide & download the legal documents
•
check if an organisation is already registered
•
get the information on expert database
•
contact the support services or check FAQs
Registered users may:
•
submit the proposal
•
sign the grant
•
manage their project throughout its lifecycle
•
register as an expert
36
Funding
opportunities
37
How to participate
38
Registration process
•Fill in your email address and the security check
•Follow the instruction given in the email received
39
PARTICIPANT PORTAL
ECAS ACCOUNT
40
Obtaining PIC
•
MY ORGANISATION
REGISTER
•
•
STEP 1: ECAS account
STEP 2: Start the registration of an organization
START REGISTRATION
basic legal information (Registration extract, VAT data) of your organization needed
•
STEP 3: Finalize the organization registration and receive a PIC number
41
Once logged in …
42
42
Electronic Submission Service - SEP
The electronic proposal submission system:
•
•
•
integrated in the Participant Portal
the servise is available linked to an open call
draft and submitted proposals are accessible under the “My Proposals” tab
Steps for proposal submission
Instrument
selection
Pre-registration
Consortium setup
Edit proposal
&submission
Form filling
Submission
43
44
45
ONLINE SUBMISSION
FORMS
PROPOSAL
PART A
Administrative
PART B
Technical
Two-stages
Deadlines:
Stage-I: 14th October 2014
Stage-II: 24th February 2015
PARTE A
1) General Information
2) Participants &
Contacts (only coordinator)
3) Budget
(only Total Requested Amount)
Template pdf online sul Participant Portal
PARTE B
1) Excellence
1.1) Objectives
1.2)Relation to the Work
Programme
1.3) Concept and Approach
1.4) Ambition
2) Impact
2.1) Expected impacts
Doc Word scaricabile dal Participant Portal
Max. 15 pages!
7 pages in Health
47
Single stage
(Deadline: 15th April 2014)
PARTE A
PARTE B
1) Excellence
1) General Information
1.1) Objectives
1.2)Relation to the Work Programme
1.3) Concept and Approach
1.4) Ambition
2) Impact
2) Participants & Contacts
3) Budget
4) Ethics
Template pdf online sul Participant Portal
2.1) Expected impacts
2.2) Measures to maximize the impact
- Dissemination and exploitation of results
- Communication activities
3) Implementation
3.1) Work plan — Work packages, deliverables and
milestones
3.2) Management structure and procedures
3.3) Consortium as a whole
3.4) Resources to be committed
4) Members of the consortium
4.1) Participants (applicants)
4.2) Third parties involved in the project (including
use of third party resources)
5) Ethics and Security
Documento Word scaricabile dal Participant Portal
Max. 70 pages!
(1+2+3)
48
1: Excellence
1.1 Objectives
Describe the specific objectives for the project, which should be:
clear, measurable, realistic and achievable
within the duration of the project.
Objectives should be consistent with the expected exploitation and impact
of the project (see section 2).
49
1.2 Relation to the work programme
Indicate the work programme topic to which your proposal relates, and
explain how your proposal addresses the specific challenge and scope of
that topic, as set out in the work programme.
1.3 Concept and approach
- Describe and explain the overall concept underpinning the project: main
ideas, models or assumptions involved, trans-disciplinary considerations;
- Describe the positioning of the project e.g. where it is situated in the
spectrum from ‘idea to application’, or from ‘lab to market’.
- Describe any national or international research and innovation activities
which will be linked with the project, especially where the outputs from
these will feed into the project;
- Describe and explain the overall approach and methodology.
50
1.4 Ambition
- Describe the advance your proposal would provide beyond the state-ofthe-art, and the extent the proposed work is ambitious.
- Describe the innovation potential which the proposal represents. Where
relevant, refer to products and services already available on the market.
Please refer to the results of any patent search carried out.
2. Impact
- Describe how your project will contribute to the expected impacts set
out in the work programme, under the relevant topic;
51
3. Implementation - 3.1 Work plan
• brief presentation of the overall structure of the work plan
• timing of the different work packages and their components (Gantt chart or
similar)
• detailed work description, i.e.:
a description of each work package (table 3.1a)
a list of work packages (table 3.1b)
a list of major deliverables (table 3.1c)
• graphical presentation of the components showing how they inter-relate (Pert
chart or similar)
52
3. Implementation - 3.2 Management structure
and procedures
• Describe the organisational structure and the decision-making ( including a
list of milestones (table 3.2a))
• Explain why the organisational structure and decision-making mechanisms
are appropriate to the complexity and scale of the project
• Describe, where relevant, how effective innovation management will be
addressed in the management structure and work plan
n.b.1 Innovation management is a process which requires an understanding of
both market and technical problems, with a goal of successfully implementing
appropriate creative ideas. A new or improved product, service or process is
its typical output. It also allows a consortium to respond to an external or
internal opportunity
• Describe any critical risks, relating to project implementation, that the
stated project's objectives may not be achieved. Detail any risk mitigation
measures. Please provide a table with critical risks identified and mitigating
actions (table 3.2b)
53
3. Implementation - 3.3 Consortium as a whole
• Describe the consortium. How will it match the project’s objectives? How do the
members complement one another (and cover the value chain, where appropriate)?
In what way does each of them contribute to the project? How will they be able to
work effectively together?
• If applicable, describe the industrial/commercial involvement in the project to
ensure exploitation of the results and explain why this is consistent with and will help
to achieve the specific measures which are proposed for exploitation of the results of
the project (see section 2.3)
• Other countries: If one or more of the participants requesting EU funding is based in
a country that is not automatically eligible for such funding (entities from Member
States of the EU, from Associated Countries and from one of the countries in the
exhaustive list included in General Annex A of the work programme are automatically
eligible for EU funding), explain why the participation of the entity in question is
essential to carrying out the project
54
3. Implementation - 3.4 Resources to be
committed
•
•
a table showing number of person/months required (table 3.4a)
a table showing ‘other direct costs’ (table 3.4b) for participants where those costs
exceed 15% of the personnel costs (according to the budget table in section 3 of
the administrative proposal forms)
55
4. Members of the consortium
• a description of the legal entity and its main tasks, with an explanation of
how its profile matches the tasks in the proposal
• a curriculum vitae or description of the profile of the persons, including
their gender, who will be primarily responsible for carrying out the proposed
research and/or innovation activities
• a list of up to 5 relevant publications, and/or products, services (including
widely-used datasets or software), or other achievements relevant to the call
content
• a list of up to 5 relevant previous projects or activities, connected to the
subject of this proposal
• a description of any significant infrastructure and/or any major items of
technical equipment, relevant to the proposed work
• [any other supporting documents specified in the work programme for this
call.]
56
4. Members of the consortium
Maximum 2 pages
•
•
•
•
•
•
•
Description of the organization
Main tasks in the project
Previous relevant experiences
2/3 curriculum vitae
up to 5 relevant publications
up to 5 relevant previous projects
any significant infrastructure
57
58
GRAZIE PER L‘ATTENZIONE!
APRE
Agenzia per la Promozione della Ricerca Europea
via Cavour, 71
00184 - Roma
www.apre.it
Tel. (+39) 06-48939993
Fax. (+39) 06-48902550
Bruno Mourenza
Health NCP
mourenza@apre.it
59